“DAKO” PD-L1 IHC 22C3 pharmDx - Taiwan Registration 5e0549c5e21bac509c8f434821edf547
Access comprehensive regulatory information for “DAKO” PD-L1 IHC 22C3 pharmDx in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number 5e0549c5e21bac509c8f434821edf547 and manufactured by Agilent Technologies, Inc.. The authorized representative in Taiwan is SCN TRADING COMPANY LIMITED.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
5e0549c5e21bac509c8f434821edf547
Ministry of Health Medical Device Import No. 028961
DHA05602896109
Product Details
Efficacy changed to (cancellation of tumor indication - uroepithelial carcinoma): detailed as approved Chinese instructions.
B Hematology and pathology devices
B1860 Immunopathological histochemical reagents and kits
Imported from abroad
Dates and Status
Nov 24, 2016
Nov 24, 2026

